Holen Sie sich die Stockscreener-App
2.11
0.48%
0.010
Handel nachbörslich:
2.11
Schlusskurs vom Vortag:
$2.10
Offen:
$2.08
24-Stunden-Volumen:
3.57M
Relative Volume:
1.81
Marktkapitalisierung:
$783.14M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.9906
EPS:
-1.06
Netto-Cashflow:
$-46.12M
1W Leistung:
+20.57%
1M Leistung:
+14.05%
6M Leistung:
-15.94%
1J Leistung:
+0.96%
1-Tages-Spanne:
$2.06
$2.23
1-Wochen-Bereich:
$1.72
$2.26
52-Wochen-Spanne:
$1.21
$3.04
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Vanguard Group Inc's Strategic Acquisition in Standard BioTools Inc - GuruFocus.com
Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17 - Yahoo Finance
TD Cowen trims Standard BioTools target, sees upside in margins and SomaScan performance - Investing.com Australia
Standard BioTools Q3 2024 Earnings Preview - MSN
Standard BioTools Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Earnings call: Standard BioTools faces mixed Q3 results amid market challenges - Investing.com Australia
Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... - Yahoo Finance
Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... By GuruFocus - Investing.com Canada
Standard BioTools Inc. (NASDAQ:LAB) Q3 2024 Earnings Call Transcript - Insider Monkey
Standard BioTools price target lowered to $2.50 from $2.75 at TD Cowen - TipRanks
Standard BioTools to Participate in Upcoming Investor Conferences - GlobeNewswire
Standard Biotools earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Standard BioTools Inc. Reports Q3 2024 Financial Performance - TipRanks
Standard BioTools: Q3 Earnings Snapshot - mySA
Standard BioTools reports Q3 EPS (7c), consensus (9c) - TipRanks
Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Standard BioTools Reports Strong Q3 2024 Performance - TipRanks
Standard BioTools, SomaLogic fall after shareholder nod for merger - MSN
Standard BioTools Reports Third Quarter 2024 Financial Results - GlobeNewswire
Standard BioTools Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Standard BioTools (NASDAQ:LAB) Trading 5.9% HigherShould You Buy? - MarketBeat
Standard BioTools And 2 Other Penny Stocks Executives Are Buying - MSN
Standard BioTools (NASDAQ:LAB) Has Debt But No Earnings; Should You Worry? - Simply Wall St
Standard BioTools (LAB) to Release Earnings on Wednesday - MarketBeat
Millennium Management LLC Acquires Shares in Standard BioTools Inc - Yahoo Finance
Millennium Management LLC Acquires Shares in Standard BioTools I - GuruFocus.com
LABStandard BioTools Inc. Latest Stock News & Market Updates - StockTitan
Standard BioTools Announces Conference Call and Webcast for - GlobeNewswire
Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024 - StockTitan
Get in on Standard BioTools Inc’s (LAB) buy-in window today! - SETE News
Financial Analysis: Standard BioTools Inc (LAB)’s Ratios Unveil Key Insights - The Dwinnex
A Guide To The Risks Of Investing In Standard BioTools Inc (LAB) - Knox Daily
Standard BioTools (NASDAQ:LAB) Trading Down 4%Time to Sell? - MarketBeat
Can you now get a good deal on Standard BioTools Inc’s shares? - US Post News
Dimensional Fund Advisors LP Sells 904,474 Shares of Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Taking a look at what insiders are doing to gauge the Standard BioTools Inc (LAB)’s direction - Knox Daily
Standard BioTools Inc (LAB) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Can you still get a good price for Standard BioTools Inc (LAB) Shares at this point? - US Post News
Millennium Management LLC Reduces Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Understanding the Risks of Investing in Standard BioTools Inc (LAB) - Knox Daily
Standard BioTools Inc (LAB) expanding its growth trajectory ahead - SETE News
19,143 Shares in Standard BioTools Inc. (NASDAQ:LAB) Purchased by Xponance Inc. - Defense World
Renaissance Technologies LLC Has $1.78 Million Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc [LAB] Shares Fall Approximately -31.87% Over the Year - Knox Daily
Is Standard BioTools Inc. (LAB) the Best NASDAQ Stock Under $5? - Insider Monkey
Is Standard BioTools Inc (LAB) a good investment opportunity? - US Post News
Standard BioTools Inc (LAB) receives a Buy rating from TD Cowen - Knox Daily
Standard BioTools Inc (LAB) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Standard BioTools (NASDAQ:LAB) Stock Quotes, Forecast and News Summary - Benzinga
Standard BioTools Inc [LAB] Shares Fall -7.11 % on Wednesday - Knox Daily
Standard BioTools Inc (LAB) Stock: Navigating Drops and Gains - The InvestChronicle
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
1.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):